Innomy (alternative proteins based on mushrooms) raises €1.3 million in funding
The round was led by Corp. Cervino, Rockstart, Zubi Capital, Eatable Adventures and CNTA
The Spanish startup Innomy has raised 1,3 million euros in its Pre Series A funding round. The round was led by international investors as Corporación Cervino, Rockstart, Zubi Capital, Eatable Adventures and the National Center for Technology and Food Safety (CNTA), who have taken equity stakes in the company to scale the startup’s disruptive technology and promote a much more sustainable and healthier protein consumption alternative in other markets.
The leading Argentinian team, composed by CEO and co-founder Juan Pablo de Giacomi, biotechnologist COO and co-founder Pablo Sánchez Rey, and mycologist CSO and Technology Partner Francisco Kuhar, has dedicated years of research to the properties of mushroom-based proteins and their benefits for the health of people and the planet.
Innomy is the third foodtech Spanish startup announcing its first funding round after successfully completing the acceleration program Spain Foodtech developed by Eatable Adventures, in collaboration with ICEX Spain Export and Investment and the National Center for Technology and Food Safety (CNTA) and the Rockstart AgriFood program. Disruptive startups Cocuus and Moa Foodtech were also selected in Spain Foodtech program.
Juan Pablo de Giacomi, CEO and founder of Innomy states "We were born as a platform to channel many years of research in the field of the properties of edible mushrooms. Our mission is to respond to consumers that demand good food products for their health but also for the planet's wellbeing. We want to reach new markets and bring our product to thousands of people".
Mycelium, a filamentous, protein-rich ingredient extracted from the root structure of mushrooms is considered to be one of the most promising sources of protein for the future. Its quality in terms of nutrition was recognized by scientists a long time ago, but its current production for human consumption is not yet widespread. Furthermore, the fact that fungi do not produce cholesterol or significant amounts of saturated fats has redirected the attention of the food industry towards them.
EFA News - European Food Agency